Akumin (AKU) Stock Price, News & Analysis

Company Overview

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida. On October 22, 2023, Akumin Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 12,903 shs
• Average Volume: 7,202 shs
• Market Capitalization: C$37.20 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AKU Stock Analysis - Frequently Asked Questions

How do I buy shares of Akumin?

Shares of AKU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Akumin own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Akumin investors own include Birchcliff Energy (BIR), AutoZone (AZO), Grupo Aval Acciones y Valores (AVAL), Magna International (MGA), Medexus Pharmaceuticals (MEDXF), Moleculin Biotech (MBRX) and Linamar (LNR).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: TSE:AKU
• CIK: N/A
• Web: www.akumin.com
• Phone: 416-613-1391
• Fax: N/A
• Employees: 1,527
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($3.80)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$255.80 million
• Net Margins: -34.67%
• Pretax Margin: N/A
• Return on Equity: -483.86%
• Return on Assets: 0.47%

Debt

• Debt-to-Equity Ratio: 266,886.35
• Current Ratio: 0.12
• Quick Ratio: 1.03

Sales & Book Value

• Annual Sales: C$737.69 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 1.96
• Book Value: C($2.86) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 70,180,000
• Free Float: N/A
• Market Cap: C$37.20 million
• Optionable: Not Optionable
• Beta: 0.15